Visium Asset Management’s DexCom DXCM Stock Holding History

Visium Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-427,552	Closed	-$7.26M	–	389
2016 Q1	$7.26M	Buy	+427,552	New	+$7.14M	0.12%	200
2015 Q3	–	Sell	-17,232	Closed	-$345K	–	973
2015 Q2	$345K	Buy	+17,232	New	+$303K	﹤0.01%	757

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Visium Asset Management's DXCM Position: Q2 2016 in Review

Visium Asset Management sold out of DexCom (DXCM) in Q2 2016, closing a stake of 427,552 shares — an estimated $7.26M sold.

Visium Asset Management first reported a position in DXCM in Q2 2015 and held it in 2 quarters. The position peaked at $7.26M in Q1 2016. 279 funds tracked by Wall St. Rank hold DXCM as of Q2 2016.

Visium Asset Management reported no remaining DexCom position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 427,552 DexCom shares in Q2 2016, an estimated $7.26M.
Visium Asset Management first reported a position in DexCom in Q2 2015 and held it in 2 quarters.
Visium Asset Management's DexCom position peaked at $7.26M in Q1 2016.
279 funds tracked by Wall St. Rank held DexCom as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.